117 related articles for article (PubMed ID: 38058259)
1. Akkermansia muciniphila might improve anti-PD-1 therapy against HCC by changing host bile acid metabolism.
Lan X; Ma J; Huang Z; Xu Y; Hu Y
J Gene Med; 2024 Jan; 26(1):e3639. PubMed ID: 38058259
[TBL] [Abstract][Full Text] [Related]
2. Landscape of tumoral ecosystem for enhanced anti-PD-1 immunotherapy by gut Akkermansia muciniphila.
Zhu Z; Huang J; Zhang Y; Hou W; Chen F; Mo YY; Zhang Z
Cell Rep; 2024 May; 43(6):114306. PubMed ID: 38819989
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles from
Luo ZW; Xia K; Liu YW; Liu JH; Rao SS; Hu XK; Chen CY; Xu R; Wang ZX; Xie H
Int J Nanomedicine; 2021; 16():2949-2963. PubMed ID: 33907401
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy.
Zhang Z; Shi X; Ji J; Guo Y; Peng Q; Hao L; Xue Y; Liu Y; Li C; Lu J; Yu K
Front Med; 2023 Aug; 17(4):729-746. PubMed ID: 37121958
[TBL] [Abstract][Full Text] [Related]
5.
Fang J; Zhang H; Zhang X; Lu X; Liu J; Li H; Huang J
Future Microbiol; 2024 Apr; ():. PubMed ID: 38629914
[No Abstract] [Full Text] [Related]
6. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.
Derosa L; Routy B; Thomas AM; Iebba V; Zalcman G; Friard S; Mazieres J; Audigier-Valette C; Moro-Sibilot D; Goldwasser F; Silva CAC; Terrisse S; Bonvalet M; Scherpereel A; Pegliasco H; Richard C; Ghiringhelli F; Elkrief A; Desilets A; Blanc-Durand F; Cumbo F; Blanco A; Boidot R; Chevrier S; Daillère R; Kroemer G; Alla L; Pons N; Le Chatelier E; Galleron N; Roume H; Dubuisson A; Bouchard N; Messaoudene M; Drubay D; Deutsch E; Barlesi F; Planchard D; Segata N; Martinez S; Zitvogel L; Soria JC; Besse B
Nat Med; 2022 Feb; 28(2):315-324. PubMed ID: 35115705
[TBL] [Abstract][Full Text] [Related]
7. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
8. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.
Liu H; Shen J; Lu K
Biochem Biophys Res Commun; 2017 Apr; 486(2):239-244. PubMed ID: 28254435
[TBL] [Abstract][Full Text] [Related]
9. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
10. Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma.
Liu X; Zhou J; Wu H; Chen S; Zhang L; Tang W; Duan L; Wang Y; McCabe E; Hu M; Yu Z; Liu H; Choi CHJ; Sung JJ; Huang L; Liu R; Cheng AS
Mol Ther; 2023 Jan; 31(1):119-133. PubMed ID: 36146933
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of
Grajeda-Iglesias C; Durand S; Daillère R; Iribarren K; Lemaitre F; Derosa L; Aprahamian F; Bossut N; Nirmalathasan N; Madeo F; Zitvogel L; Kroemer G
Aging (Albany NY); 2021 Mar; 13(5):6375-6405. PubMed ID: 33653967
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma.
Jiang G; Shi L; Zheng X; Zhang X; Wu K; Liu B; Yan P; Liang X; Yu T; Wang Y; Cai X
Aging (Albany NY); 2020 Jun; 12(12):11466-11484. PubMed ID: 32579541
[TBL] [Abstract][Full Text] [Related]
13. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
14.
Gu Z; Pei W; Shen Y; Wang L; Zhu J; Zhang Y; Fan S; Wu Q; Li L; Zhang Z
Food Funct; 2021 Oct; 12(20):10184-10195. PubMed ID: 34532729
[TBL] [Abstract][Full Text] [Related]
15. MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
Wan JL; Wang B; Wu ML; Li J; Gong RM; Song LN; Zhang HS; Zhu GQ; Chen SP; Cai JL; Xing XX; Wang YD; Yang Y; Cai CZ; Huang R; Liu H; Dai Z
Cancer Lett; 2022 Aug; 541():215750. PubMed ID: 35609735
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma.
Zheng Y; Wang T; Tu X; Huang Y; Zhang H; Tan D; Jiang W; Cai S; Zhao P; Song R; Li P; Qin N; Fang W
J Immunother Cancer; 2019 Jul; 7(1):193. PubMed ID: 31337439
[TBL] [Abstract][Full Text] [Related]
17. Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance.
Shi L; Sheng J; Chen G; Zhu P; Shi C; Li B; Park C; Wang J; Zhang B; Liu Z; Yang X
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028692
[TBL] [Abstract][Full Text] [Related]
18.
Qiao CM; Huang WY; Zhou Y; Quan W; Niu GY; Li T; Zhang MX; Wu J; Zhao LP; Zhao WJ; Cui C; Shen YQ
Brain Sci; 2024 Feb; 14(3):. PubMed ID: 38539626
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice.
Shi J; Zhu L; Tang BY; Yang WQ; Xi SY; Zhang CL; Li PF; Wang YJ; Guo KH; Huang JR; Huang CR; Yu ZX; Yu BK; Zhang CF; Zhang YM
J Nat Med; 2024 Jun; 78(3):633-643. PubMed ID: 38704807
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer's disease.
Ou Z; Deng L; Lu Z; Wu F; Liu W; Huang D; Peng Y
Nutr Diabetes; 2020 Apr; 10(1):12. PubMed ID: 32321934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
